Literature DB >> 6489371

The effect of specimen processing on radiolabeled monoclonal antibody biodistribution.

R L Wahl, P Sherman, S Fisher.   

Abstract

Monoclonal antibodies are assuming increasing importance in experimental and clinical medicine. Generally, tissue biodistribution studies in animals precede human studies. To investigate a concern of ours that varying methods of sample handling in these studies could result in apparent alterations in tissue-binding levels, we compared two methods of tissue processing after the administration of labeled antibodies: one including only blotting away of blood, the other involving several washing steps. The unwashed, blotted specimens were found to have significantly more radioactivity per gram of tissue than the washed, ranging from 22% more in the spleen to 52% more in the lungs and left ventricle. Since in vivo imaging is dependent on the total mount of radioactivity in an organ, we believe the most meaningful determination of tissue radioactivity should be based on unwashed samples. Awareness of this problem is suggested to allow meaningful extrapolations from measured tissue localization data to imaging and therapy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6489371     DOI: 10.1007/bf00252876

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  11 in total

1.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  Accumulation of homologous radioiodinated albumin in experimental tumors.

Authors:  F K BAUER; M TUBIS; H B THOMAS
Journal:  Proc Soc Exp Biol Med       Date:  1955-10

3.  Use of 131-I-CEA antibody as a tumor scanning agent.

Authors:  P B Hoffer; K Lathrop; C Bekerman; V S Fang; S Refetoff
Journal:  J Nucl Med       Date:  1974-05       Impact factor: 10.057

4.  Localization of human GW-39 tumors in hamsters by radiolabeled heterospecific antibody to carcinoembryonic antigen.

Authors:  F J Primus; R H Wang; D M Goldenberg; H J Hansen
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

5.  Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy.

Authors:  J P Mach; F Buchegger; M Forni; J Ritschard; C Berche; J D Lumbroso; M Schreyer; C Girardet; R S Accolla; S Carrel
Journal:  Immunol Today       Date:  1981-12

6.  Antibody as carrier of 131I in cancer diagnosis and treatment.

Authors:  T Ghose; A Guclu; J Tai; A S MacDonald; S T Norvell; J Aquino
Journal:  Cancer       Date:  1975-11       Impact factor: 6.860

7.  Localization of 111In- and 125I-labeled monoclonal antibody in guinea pigs bearing line 10 hepatocarcinoma tumors.

Authors:  M I Bernhard; K M Hwang; K A Foon; A M Keenan; R M Kessler; J M Frincke; D J Tallam; M G Hanna; L Peters; R K Oldham
Journal:  Cancer Res       Date:  1983-09       Impact factor: 12.701

8.  Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning.

Authors:  D M Goldenberg; F DeLand; E Kim; S Bennett; F J Primus; J R van Nagell; N Estes; P DeSimone; P Rayburn
Journal:  N Engl J Med       Date:  1978-06-22       Impact factor: 91.245

9.  Improved radioimaging and tumor localization with monoclonal F(ab')2.

Authors:  R L Wahl; C W Parker; G W Philpott
Journal:  J Nucl Med       Date:  1983-04       Impact factor: 10.057

10.  Monoclonal antibody radioimmunodetection of human-derived colon cancer.

Authors:  R L Wahl; G Philpott; C W Parker
Journal:  Invest Radiol       Date:  1983 Jan-Feb       Impact factor: 6.016

View more
  4 in total

1.  Differences in tumour and normal tissue concentrations of iodine- and indium-labelled monoclonal antibody. II. Biodistribution studies in mice with human tumour xenografts.

Authors:  M V Pimm; A C Perkins; R W Baldwin
Journal:  Eur J Nucl Med       Date:  1985

2.  Improved radioimmunolocalization of human tumor xenografts following subcutaneous delivery of monoclonal antibodies.

Authors:  R L Wahl; L Laino; S Fisher; M Schteingart; W H Beierwaltes
Journal:  Eur J Nucl Med       Date:  1988

3.  High-dose, unlabeled, nonspecific antibody pretreatment: influence on specific antibody localization to human melanoma xenografts.

Authors:  R L Wahl; B S Wilson; M Liebert; W H Beierwaltes
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

4.  Quantitative autoradiographic evaluation of the influence of protein dose on monoclonal antibody distribution in human ovarian adenocarcinoma xenografts.

Authors:  F E Yang; R S Brown; K F Koral; A C Clavo; G A Jackson; R L Wahl
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.